1. Medtech Insight
  2. >>Device Area
  3. >>Diagnostics
  4. >>In Vitro Diagnostics

Abbott Adds IgM Test To COVID-19 Diagnostic Line-Up

 
• By Reed Miller

The FDA has granted an emergency use authorization for a COVID-19 IgM antibody blood test that runs on Abbott’s Architect and Alinity platforms.

Antibodies immunoglobulins attacking coronavirus covid-19 influenza virus cell, 3D immune system medical illustration background. Corona virus 2019-ncov sars cell, igm. Coronavirus sars-cov-2 disease
• Source: shutterstock.com

Abbott is launching a COVID-19 immunoglobulin M (IgM) lab-based antibody test to complement the immunoglobulin G (IgG) test it launched in April.

On 12 October, the company announced that the US Food and Drug Administration has granted an emergency use authorization...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from In Vitro Diagnostics

More from Diagnostics